Advertisement

Index by author

February 01, 2017; Volume 45,Issue 2

A

  1. Agnani, Deep

    1. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

  2. Ahituv, Nadav

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  3. Annes, William F.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

  4. Asakura, Mitsutoshi

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

  5. Atsuda, Koichiro

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

  6. Ayan-Oshodi, Mosun A.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

B

  1. Bellanti, Francisco

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  2. Bennink, Roelof J.

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  3. Benoit, Etienne

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  4. Bentz, Joe

    1. Extrapolation of Elementary Rate Constants of P-glycoprotein–Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells
      Zhou Meng, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 190-197; DOI: https://doi.org/10.1124/dmd.116.072140
    2. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

  5. Bhatt, Deepak Kumar

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

  6. Bieze, Matthanja

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  7. Boberg, Mikael

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

C

  1. Cao, Li

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  2. Caruel, Hervé

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  3. Cooper, Kirsten L.

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  4. Cristea, Sinziana

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

D

  1. Damin-Pernik, Marlène

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  2. de Lange, Elizabeth C. M.

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  3. den Hoedt, Sandra M.

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

E

  1. Eclov, Rachel J.

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  2. Ellens, Harma

    1. Extrapolation of Elementary Rate Constants of P-glycoprotein–Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells
      Zhou Meng, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 190-197; DOI: https://doi.org/10.1124/dmd.116.072140
    2. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

  3. Espana, Bernadette

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

F

  1. Faris, Ronald A.

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  2. Fourel, Isabelle

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  3. Fujii, Hideaki

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

  4. Fujiwara, Ryoichi

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

  5. Fukami, Tatsuki

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

G

  1. Gaedigk, Andrea

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

  2. Geuer, Jana K.

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  3. Grey, Anne K. Mullen

    1. Role of Glucocorticoid Receptor and Pregnane X Receptor in Dexamethasone Induction of Rat Hepatic Aryl Hydrocarbon Receptor Nuclear Translocator and NADPH-Cytochrome P450 Oxidoreductase
      Sarah R. Hunter, Alex Vonk, Anne K. Mullen Grey and David S. Riddick
      Drug Metabolism and Disposition February 2017, 45 (2) 118-129; DOI: https://doi.org/10.1124/dmd.116.073833

H

  1. Hartman, Robin

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  2. Hiller, Christian

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  3. Hillgren, Kathleen M.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

  4. Hofstetter, Lia

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  5. Hong, Yulong

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  6. Hu, Yongjun

    1. Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants
      Feifeng Song, Yongjun Hu, Huidi Jiang and David E. Smith
      Drug Metabolism and Disposition February 2017, 45 (2) 130-136; DOI: https://doi.org/10.1124/dmd.116.073320

  7. Hunter, Sarah R.

    1. Role of Glucocorticoid Receptor and Pregnane X Receptor in Dexamethasone Induction of Rat Hepatic Aryl Hydrocarbon Receptor Nuclear Translocator and NADPH-Cytochrome P450 Oxidoreductase
      Sarah R. Hunter, Alex Vonk, Anne K. Mullen Grey and David S. Riddick
      Drug Metabolism and Disposition February 2017, 45 (2) 118-129; DOI: https://doi.org/10.1124/dmd.116.073833

I

  1. Itoh, Tomoo

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

J

  1. Jiang, Huidi

    1. Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants
      Feifeng Song, Yongjun Hu, Huidi Jiang and David E. Smith
      Drug Metabolism and Disposition February 2017, 45 (2) 130-136; DOI: https://doi.org/10.1124/dmd.116.073320

  2. Johne, Andreas

    1. Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Holger Scheible, Friedrich Kraetzer, Andreas Marx, Andreas Johne and Elmar Wimmer
      Drug Metabolism and Disposition February 2017, 45 (2) 174-182; DOI: https://doi.org/10.1124/dmd.116.072934

K

  1. Kim, Mee J.

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  2. Knadler, Mary Pat

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

  3. Koepsell, Hermann

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  4. Kraetzer, Friedrich

    1. Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Holger Scheible, Friedrich Kraetzer, Andreas Marx, Andreas Johne and Elmar Wimmer
      Drug Metabolism and Disposition February 2017, 45 (2) 174-182; DOI: https://doi.org/10.1124/dmd.116.072934

  5. Kroetz, Deanna L.

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  6. Kullak-Ublick, Gerd A.

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

L

  1. Lai, W. George

    1. Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor
      Y. Amy Siu and W. George Lai
      Drug Metabolism and Disposition February 2017, 45 (2) 183-189; DOI: https://doi.org/10.1124/dmd.116.073510

  2. Lai, Yurong

    1. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier
      Hong Shen, Yurong Lai and A. David Rodrigues
      Drug Metabolism and Disposition February 2017, 45 (2) 228-236; DOI: https://doi.org/10.1124/dmd.116.072264

  3. Lattard, Virginie

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  4. Leeder, J. Steven

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

  5. Leese, Phillip

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

  6. Lefebvre, Sebastien

    1. Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
      Marlène Damin-Pernik, Bernadette Espana, Sebastien Lefebvre, Isabelle Fourel, Hervé Caruel, Etienne Benoit and Virginie Lattard
      Drug Metabolism and Disposition February 2017, 45 (2) 160-165; DOI: https://doi.org/10.1124/dmd.116.073791

  7. Le Marchand, Sylvain

    1. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

  8. Li, Daochuan

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  9. Li, Feng

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  10. Liang, Xiaomin

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  11. Liu, Jin

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  12. Long, Amanda J.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

M

  1. Mangas-Sanjuan, Victor

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  2. Marx, Andreas

    1. Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Holger Scheible, Friedrich Kraetzer, Andreas Marx, Andreas Johne and Elmar Wimmer
      Drug Metabolism and Disposition February 2017, 45 (2) 174-182; DOI: https://doi.org/10.1124/dmd.116.072934

  3. Mehrotra, Aanchal

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

  4. Meng, Zhou

    1. Extrapolation of Elementary Rate Constants of P-glycoprotein–Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells
      Zhou Meng, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 190-197; DOI: https://doi.org/10.1124/dmd.116.072140
    2. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

  5. Mitchell, Malcolm I.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

N

  1. Nakajima, Miki

    1. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
      Mitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
      Drug Metabolism and Disposition February 2017, 45 (2) 237-245; DOI: https://doi.org/10.1124/dmd.116.073866

  2. Nakanishi, Takeo

    1. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions
      Kei Nishizawa, Takeo Nakanishi and Ikumi Tamai
      Drug Metabolism and Disposition February 2017, 45 (2) 224-227; DOI: https://doi.org/10.1124/dmd.116.072355

  3. Nishizawa, Kei

    1. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions
      Kei Nishizawa, Takeo Nakanishi and Ikumi Tamai
      Drug Metabolism and Disposition February 2017, 45 (2) 224-227; DOI: https://doi.org/10.1124/dmd.116.072355

P

  1. Pak, Y. Anne

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

  2. Parikh, Sweta

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  3. Pearce, Robin E.

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

  4. Phoa, Saffire S.K.S.

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  5. Prasad, Bhagwat

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

R

  1. Riddick, David S.

    1. Role of Glucocorticoid Receptor and Pregnane X Receptor in Dexamethasone Induction of Rat Hepatic Aryl Hydrocarbon Receptor Nuclear Translocator and NADPH-Cytochrome P450 Oxidoreductase
      Sarah R. Hunter, Alex Vonk, Anne K. Mullen Grey and David S. Riddick
      Drug Metabolism and Disposition February 2017, 45 (2) 118-129; DOI: https://doi.org/10.1124/dmd.116.073833

  2. Rodrigues, A. David

    1. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier
      Hong Shen, Yurong Lai and A. David Rodrigues
      Drug Metabolism and Disposition February 2017, 45 (2) 228-236; DOI: https://doi.org/10.1124/dmd.116.072264

S

  1. Scheible, Holger

    1. Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Holger Scheible, Friedrich Kraetzer, Andreas Marx, Andreas Johne and Elmar Wimmer
      Drug Metabolism and Disposition February 2017, 45 (2) 174-182; DOI: https://doi.org/10.1124/dmd.116.072934

  2. Shen, Hong

    1. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier
      Hong Shen, Yurong Lai and A. David Rodrigues
      Drug Metabolism and Disposition February 2017, 45 (2) 228-236; DOI: https://doi.org/10.1124/dmd.116.072264

  3. Shimizu, Shinji

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  4. Siu, Y. Amy

    1. Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor
      Y. Amy Siu and W. George Lai
      Drug Metabolism and Disposition February 2017, 45 (2) 183-189; DOI: https://doi.org/10.1124/dmd.116.073510

  5. Smith, David E.

    1. Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants
      Feifeng Song, Yongjun Hu, Huidi Jiang and David E. Smith
      Drug Metabolism and Disposition February 2017, 45 (2) 130-136; DOI: https://doi.org/10.1124/dmd.116.073320

  6. Smith, Robin P.

    1. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
      Rachel J. Eclov, Mee J. Kim, Robin P. Smith, Xiaomin Liang, Nadav Ahituv and Deanna L. Kroetz
      Drug Metabolism and Disposition February 2017, 45 (2) 208-215; DOI: https://doi.org/10.1124/dmd.116.072033

  7. Song, Feifeng

    1. Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants
      Feifeng Song, Yongjun Hu, Huidi Jiang and David E. Smith
      Drug Metabolism and Disposition February 2017, 45 (2) 130-136; DOI: https://doi.org/10.1124/dmd.116.073320

  8. Stieger, Bruno

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  9. Szapacs, Matthew

    1. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers
      Zhou Meng, Sylvain Le Marchand, Deep Agnani, Matthew Szapacs, Harma Ellens and Joe Bentz
      Drug Metabolism and Disposition February 2017, 45 (2) 145-151; DOI: https://doi.org/10.1124/dmd.116.072157

T

  1. Tamai, Ikumi

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371
    2. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions
      Kei Nishizawa, Takeo Nakanishi and Ikumi Tamai
      Drug Metabolism and Disposition February 2017, 45 (2) 224-227; DOI: https://doi.org/10.1124/dmd.116.072355

V

  1. van den Berg, Dirk-Jan

    1. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat
      Shinji Shimizu, Sandra M. den Hoedt, Victor Mangas-Sanjuan, Sinziana Cristea, Jana K. Geuer, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti and Elizabeth C. M. de Lange
      Drug Metabolism and Disposition February 2017, 45 (2) 152-159; DOI: https://doi.org/10.1124/dmd.116.072306

  2. van Gulik, Thomas M.

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  3. van Rosmalen, Belle V.

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  4. Verheij, Joanne

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  5. Visentin, Michele

    1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
      Michele Visentin, Belle V. van Rosmalen, Christian Hiller, Matthanja Bieze, Lia Hofstetter, Joanne Verheij, Gerd A. Kullak-Ublick, Hermann Koepsell, Saffire S.K.S. Phoa, Ikumi Tamai, Roelof J. Bennink, Thomas M. van Gulik and Bruno Stieger
      Drug Metabolism and Disposition February 2017, 45 (2) 166-173; DOI: https://doi.org/10.1124/dmd.116.072371

  6. Vonk, Alex

    1. Role of Glucocorticoid Receptor and Pregnane X Receptor in Dexamethasone Induction of Rat Hepatic Aryl Hydrocarbon Receptor Nuclear Translocator and NADPH-Cytochrome P450 Oxidoreductase
      Sarah R. Hunter, Alex Vonk, Anne K. Mullen Grey and David S. Riddick
      Drug Metabolism and Disposition February 2017, 45 (2) 118-129; DOI: https://doi.org/10.1124/dmd.116.073833

  7. Vrana, Marc

    1. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
      Mikael Boberg, Marc Vrana, Aanchal Mehrotra, Robin E. Pearce, Andrea Gaedigk, Deepak Kumar Bhatt, J. Steven Leeder and Bhagwat Prasad
      Drug Metabolism and Disposition February 2017, 45 (2) 216-223; DOI: https://doi.org/10.1124/dmd.116.072652

W

  1. Wang, Hongbing

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124

  2. Wimmer, Elmar

    1. Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors
      Holger Scheible, Friedrich Kraetzer, Andreas Marx, Andreas Johne and Elmar Wimmer
      Drug Metabolism and Disposition February 2017, 45 (2) 174-182; DOI: https://doi.org/10.1124/dmd.116.072934

  3. Witcher, Jennifer W.

    1. Open Access
      In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
      Y. Anne Pak, Amanda J. Long, William F. Annes, Jennifer W. Witcher, Mary Pat Knadler, Mosun A. Ayan-Oshodi, Malcolm I. Mitchell, Phillip Leese and Kathleen M. Hillgren
      Drug Metabolism and Disposition February 2017, 45 (2) 137-144; DOI: https://doi.org/10.1124/dmd.116.071118

Z

  1. Zuo, Rongjun

    1. Open Access
      Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach
      Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li and Hongbing Wang
      Drug Metabolism and Disposition February 2017, 45 (2) 198-207; DOI: https://doi.org/10.1124/dmd.116.072124
Back to top

In this issue

Advertisement